Format

Send to

Choose Destination
See comment in PubMed Commons below
Mult Scler. 2012 Aug;18(8):1188-92. doi: 10.1177/1352458511434067. Epub 2012 Jan 17.

No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients.

Author information

  • 1Institute of Neuroimmunology and Clinical MS Research, Center for Molecular Neurobiology Hamburg, Germany. andreas.lutterotti@i-med.ac.at

Abstract

Autologous hematopoietic stem cell transplantation (aHSCT) has been used as a therapeutic approach in multiple sclerosis (MS). However, it is still unclear if the immune system that emerges from autologous CD34+ hematopoietic progenitor cells (HPC) of MS patients is pre-conditioned to re-develop the proinflammatory phenotype. The objective of this article is to compare the whole genome gene and microRNA expression signature in CD34+ HPC of MS patients and healthy donors (HD). CD34+ HPC were isolated from peripheral blood of eight MS patients and five HD and analyzed by whole genome gene expression and microRNA expression microarray. Among the differentially expressed genes (DEGs) only TNNT1 reached statistical significance (logFC=3.1, p<0.01). The microRNA expression was not significantly different between MS patients and HD. We did not find significant alterations of gene expression or microRNA profiles in CD34+ HPCs of MS patients. Our results support the use of aHSCT for treatment of MS.

PMID:
22252466
DOI:
10.1177/1352458511434067
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center